Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
出版年份 2021 全文链接
标题
Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-12
DOI
10.3389/fonc.2021.587554
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Direct interaction between CEP85 and STIL mediates PLk4-driven directed cell migration
- (2020) Yi Liu et al. JOURNAL OF CELL SCIENCE
- Inhibition of PLK4 might enhance the anti‐tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway
- (2020) Jing Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
- (2020) Qingyang Lei et al. Frontiers in Cell and Developmental Biology
- Polo‑like kinase�4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma
- (2019) Jia Wang et al. ONCOLOGY REPORTS
- Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer
- (2019) Amreena Suri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lung Cancer
- (2019) Faria Nasim et al. MEDICAL CLINICS OF NORTH AMERICA
- Role for polo-like kinase 4 in mediation of cytokinesis
- (2019) Michael F. Press et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma
- (2019) Kazuya Shinmura et al. Cancers
- Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability
- (2019) Dong Hyun Kim et al. Cell Death & Disease
- Self-organization of Plk4 regulates symmetry breaking in centriole duplication
- (2019) Shohei Yamamoto et al. Nature Communications
- A cis ‐eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma
- (2019) Lijuan Meng et al. Cancer Medicine
- PLK 4 deubiquitination by Spata2‐CYLD suppresses NEK7‐mediated NLRP3 inflammasome activation at the centrosome
- (2019) Xiao‐Dong Yang et al. EMBO JOURNAL
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Phase separation of Polo-like kinase 4 by autoactivation and clustering drives centriole biogenesis
- (2019) Jung-Eun Park et al. Nature Communications
- Polo‐like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non‐small cell lung cancer
- (2019) Qin Zhou et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
- (2019) Devesh Tewari et al. SEMINARS IN CANCER BIOLOGY
- Cervical Cancer Worldwide
- (2018) Mailinh Vu et al. CURRENT PROBLEMS IN CANCER
- Emerging therapeutic targets for the treatment of malignant rhabdoid tumors
- (2018) Karolina Nemes et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA
- (2018) Thomas X. Lu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Fast and furious . . . or not, Plk4 dictates the pace
- (2018) Simon Gemble et al. JOURNAL OF CELL BIOLOGY
- Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma
- (2018) Ryan A. Denu et al. MOLECULAR CANCER RESEARCH
- Once and only once: mechanisms of centriole duplication and their deregulation in disease
- (2018) Erich A. Nigg et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Arp2/3 Regulatory System and Its Deregulation in Cancer
- (2018) Nicolas Molinie et al. PHYSIOLOGICAL REVIEWS
- Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
- (2018) Masanori Kawakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway
- (2018) Xiangdong Tian et al. Cell Death & Disease
- Direct binding of CEP85 to STIL ensures robust PLK4 activation and efficient centriole assembly
- (2018) Yi Liu et al. Nature Communications
- E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments
- (2018) Wenjun Lan et al. Scientific Reports
- Exploring the links between cancer and placenta development
- (2018) Vincenzo Costanzo et al. Open Biology
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Targeting the cell cycle in breast cancer: towards the next phase
- (2018) KL Thu et al. CELL CYCLE
- Targeted Therapy and Immune Therapy for Small Cell Lung Cancer
- (2018) Shirish M. Gadgeel CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Regulating a key mitotic regulator, polo‐like kinase 1 (PLK1)
- (2018) Erica G. Colicino et al. Cytoskeleton
- EMT Transition States during Tumor Progression and Metastasis
- (2018) Ievgenia Pastushenko et al. TRENDS IN CELL BIOLOGY
- YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect
- (2018) Qian Lei et al. Cell Death & Disease
- MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway
- (2018) Jie Bao et al. Cell Death & Disease
- PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma
- (2018) Zuoxin Zhang et al. CANCER LETTERS
- Analysis of centrosome and DNA damage response in PLK4 associated Seckel syndrome
- (2017) Tuba Dinçer et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- ATAD2 in cancer: a pharmacologically challenging but tractable target
- (2017) Muzammal Hussain et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Maternal common variant rs2305957 spanning PLK4 is associated with blastocyst formation and early recurrent miscarriage
- (2017) Qian Zhang et al. FERTILITY AND STERILITY
- Integrating high-throughput screening and sequencing for monoclonal antibody discovery and engineering
- (2017) Cristina Parola et al. IMMUNOLOGY
- Cytokinesis Failure Leading to Chromosome Instability in v-Src-Induced Oncogenesis
- (2017) Yuji Nakayama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma
- (2017) Lindsey N. Kent et al. JOURNAL OF CLINICAL INVESTIGATION
- Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
- (2017) Padmanee Sharma et al. LANCET ONCOLOGY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain
- (2017) Simone Treiger Sredni et al. PEDIATRIC BLOOD & CANCER
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
- (2017) Lais Osmani et al. SEMINARS IN CANCER BIOLOGY
- Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1
- (2017) Edward J. Morris et al. Nature Communications
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
- (2017) Simone Treiger Sredni et al. Oncotarget
- Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
- (2016) Yijuan Zhang et al. ACS Nano
- A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma
- (2016) T. Ciuleanu et al. ANNALS OF ONCOLOGY
- A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
- (2016) W. M. Tai et al. ANNALS OF ONCOLOGY
- Targeting cancer using KAT inhibitors to mimic lethal knockouts
- (2016) J. A. L. Brown et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Plk4 Promotes Cancer Invasion and Metastasis through Arp2/3 Complex Regulation of the Actin Cytoskeleton
- (2016) Karineh Kazazian et al. CANCER RESEARCH
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Cep78 is a new centriolar protein involved in Plk4-induced centriole overduplication
- (2016) Kathrin Brunk et al. JOURNAL OF CELL SCIENCE
- Medulloblastoma
- (2016) Nathan E. Millard et al. JOURNAL OF CHILD NEUROLOGY
- Molecular interactions of polo-like kinase 1 in human cancers
- (2016) Wayne Tiong Weng Ng et al. JOURNAL OF CLINICAL PATHOLOGY
- Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy
- (2016) Min Yan et al. MEDICINAL RESEARCH REVIEWS
- SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
- (2016) Paul R. Elliott et al. MOLECULAR CELL
- Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies
- (2016) Michael C. Frühwald et al. NEURO-ONCOLOGY
- Functions of Polo-Like Kinases: A Journey From Yeast To Humans
- (2016) Rajni Vaid et al. PROTEIN AND PEPTIDE LETTERS
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts
- (2016) Ines Lohse et al. Oncotarget
- Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy
- (2016) Zhenhua Li et al. Journal of Cancer
- Nanoporous Glass Integrated in Volumetric Bar-Chart Chip for Point-of-Care Diagnostics of Non-Small Cell Lung Cancer
- (2015) Ying Li et al. ACS Nano
- Pancreatic Cancer: Pathogenesis and Diagnosis
- (2015) Vedat Goral Asian Pacific Journal of Cancer Prevention
- A Threshold Level of Intratumor CD8 + T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1
- (2015) Shin Foong Ngiow et al. CANCER RESEARCH
- PLK4 trans-Autoactivation Controls Centriole Biogenesis in Space
- (2015) Carla A.M. Lopes et al. DEVELOPMENTAL CELL
- MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome
- (2015) Kunning Wang et al. GUT
- Binding of STIL to Plk4 activates kinase activity to promote centriole assembly
- (2015) Tyler C. Moyer et al. JOURNAL OF CELL BIOLOGY
- The E3 ubiquitin ligase Mib1 regulates Plk4 and centriole biogenesis
- (2015) L. ajanek et al. JOURNAL OF CELL SCIENCE
- Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant
- (2015) Wies van Roosmalen et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Mitosis in Cancer: Emerging Strategies
- (2015) Carmen Dominguez-Brauer et al. MOLECULAR CELL
- Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis
- (2015) Özdemirhan Serçin et al. NATURE CELL BIOLOGY
- Understanding the Polo Kinase machine
- (2015) V Archambault et al. ONCOGENE
- The role of Plk3 in oncogenesis
- (2015) C Helmke et al. ONCOGENE
- Autoinhibition and relief mechanism for Polo-like kinase 4
- (2015) Joseph E. Klebba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Common variants spanning PLK4 are associated with mitotic-origin aneuploidy in human embryos
- (2015) R. C. McCoy et al. SCIENCE
- Reversible centriole depletion with an inhibitor of Polo-like kinase 4
- (2015) Y. L. Wong et al. SCIENCE
- PLK1 regulates spindle formation kinetics and APC/C activation in mouse zygote
- (2015) Vladimir Baran et al. ZYGOTE
- The Centrosome and Its Duplication Cycle
- (2015) Jingyan Fu et al. Cold Spring Harbor Perspectives in Biology
- Loss of KLF14 triggers centrosome amplification and tumorigenesis
- (2015) Guangjian Fan et al. Nature Communications
- Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse
- (2015) Paula A. Coelho et al. Open Biology
- STIL binding to Polo-box 3 of PLK4 regulates centriole duplication
- (2015) Christian Arquint et al. eLife
- Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
- (2015) D. S. Thommen et al. Cancer Immunology Research
- Melanoma
- (2015) Dirk Schadendorf et al. Nature Reviews Disease Primers
- CAND1 Promotes PLK4-Mediated Centriole Overduplication and Is Frequently Disrupted in Prostate Cancer
- (2015) Nina Korzeniewski et al. NEOPLASIA
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent
- (2014) Jacqueline M. Mason et al. CANCER CELL
- Plk4 Phosphorylates Ana2 to Trigger Sas6 Recruitment and Procentriole Formation
- (2014) Nikola S. Dzhindzhev et al. CURRENT BIOLOGY
- Changing incidence and improved survival of gliomas
- (2014) Vincent K.Y. Ho et al. EUROPEAN JOURNAL OF CANCER
- Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance
- (2014) Mihaela Marina Frontiers in Bioscience-Landmark
- A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity
- (2014) Yasunori Nishida et al. Gastric Cancer
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent
- (2014) Peter B. Sampson et al. JOURNAL OF MEDICINAL CHEMISTRY
- E2F Activators Signal and Maintain Centrosome Amplification in Breast Cancer Cells
- (2014) M.-Y. Lee et al. MOLECULAR AND CELLULAR BIOLOGY
- PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer
- (2014) Kazuya Shinmura et al. MOLECULAR BIOLOGY REPORTS
- Oncogene-like induction of cellular invasion from centrosome amplification
- (2014) Susana A. Godinho et al. NATURE
- Polo-like kinases: structural variations lead to multiple functions
- (2014) Sihem Zitouni et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis
- (2014) Suk-Youl Park et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A novel role for Plk4 in regulating cell spreading and motility
- (2014) C O Rosario et al. ONCOGENE
- p53-Dependent and Cell Specific Epigenetic Regulation of the Polo-like kinases under Oxidative Stress
- (2014) Alejandra Ward et al. PLoS One
- Direct interaction of Plk4 with STIL ensures formation of a single procentriole per parental centriole
- (2014) Midori Ohta et al. Nature Communications
- FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors
- (2013) Miki Kiyota et al. APOPTOSIS
- NFκB regulates expression of Polo-like kinase 4
- (2013) Adeline Ledoux et al. CELL CYCLE
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Regulation of Autophosphorylation Controls PLK4 Self-Destruction and Centriole Number
- (2013) Inês Cunha-Ferreira et al. CURRENT BIOLOGY
- Human Cep192 and Cep152 cooperate in Plk4 recruitment and centriole duplication
- (2013) K. F. Sonnen et al. JOURNAL OF CELL SCIENCE
- The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents
- (2013) Radoslaw Laufer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein
- (2013) Martin Fischer et al. NUCLEIC ACIDS RESEARCH
- Hierarchical recruitment of Plk4 and regulation of centriole biogenesis by two centrosomal scaffolds, Cep192 and Cep152
- (2013) T.-S. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance
- (2012) Kamlesh Sodani et al. BIOCHEMICAL PHARMACOLOGY
- GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo
- (2012) M. S. Raab et al. CANCER RESEARCH
- The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle
- (2012) A. J. Holland et al. GENES & DEVELOPMENT
- A Clinical Overview of Centrosome Amplification in Human Cancers
- (2012) Jason Yongsheng Chan International Journal of Biological Sciences
- Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4)
- (2012) Onur Cizmecioglu et al. JOURNAL OF CELL SCIENCE
- NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies
- (2012) B. Valsasina et al. MOLECULAR CANCER THERAPEUTICS
- Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
- (2012) Lili Liu et al. PLoS One
- The Structure of the Plk4 Cryptic Polo Box Reveals Two Tandem Polo Boxes Required for Centriole Duplication
- (2012) Lauren K. Slevin et al. STRUCTURE
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice
- (2011) Alejandra Ward et al. BMC CANCER
- Structural Basis of the 9-Fold Symmetry of Centrioles
- (2011) Daiju Kitagawa et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- From Plk1 to Plk5
- (2011) Guillermo de Cárcer et al. CELL CYCLE
- The initial phase of chromosome condensation requires Cdk1-mediated phosphorylation of the CAP-D3 subunit of condensin II
- (2011) S. Abe et al. GENES & DEVELOPMENT
- Molecular mechanisms of inflammasome activation during microbial infections
- (2011) Petr Broz et al. IMMUNOLOGICAL REVIEWS
- The Protein Phosphatase 2A regulatory subunit Twins stabilizes Plk4 to induce centriole amplification
- (2011) Christopher W. Brownlee et al. JOURNAL OF CELL BIOLOGY
- PLK1 phosphorylation of pericentrin initiates centrosome maturation at the onset of mitosis
- (2011) Kwanwoo Lee et al. JOURNAL OF CELL BIOLOGY
- Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression
- (2011) G. de Carcer et al. MOLECULAR AND CELLULAR BIOLOGY
- The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression
- (2011) Nina Korzeniewski et al. Molecular Cancer
- FBXW5 controls centrosome number
- (2011) Julia Pagan et al. NATURE CELL BIOLOGY
- The SCF–FBXW5 E3-ubiquitin ligase is regulated by PLK4 and targets HsSAS-6 to control centrosome duplication
- (2011) Anja Puklowski et al. NATURE CELL BIOLOGY
- CDK11p58 Is Required for Centriole Duplication and Plk4 Recruitment to Mitotic Centrosomes
- (2011) Nathalie Franck et al. PLoS One
- Structures of SAS-6 Suggest Its Organization in Centrioles
- (2011) M. van Breugel et al. SCIENCE
- Genomic instability and cancer: Lessons learned from human papillomaviruses
- (2010) Nina Korzeniewski et al. CANCER LETTERS
- Centriole duplication
- (2010) Andrew J. Holland et al. CELL CYCLE
- Centriole Reduplication during Prolonged Interphase Requires Procentriole Maturation Governed by Plk1
- (2010) Jadranka Lončarek et al. CURRENT BIOLOGY
- Mechanisms of Chromosomal Instability
- (2010) Sarah L. Thompson et al. CURRENT BIOLOGY
- PLK2 phosphorylation is critical for CPAP function in procentriole formation during the centrosome cycle
- (2010) Jaerak Chang et al. EMBO JOURNAL
- Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability
- (2010) Andrew J. Holland et al. JOURNAL OF CELL BIOLOGY
- Cep152 interacts with Plk4 and is required for centriole duplication
- (2010) Emily M. Hatch et al. JOURNAL OF CELL BIOLOGY
- Plk4 trans-autophosphorylation regulates centriole number by controlling TrCP-mediated degradation
- (2010) G. Guderian et al. JOURNAL OF CELL SCIENCE
- Stepwise evolution of the centriole-assembly pathway
- (2010) Z. Carvalho-Santos et al. JOURNAL OF CELL SCIENCE
- The relationship between early embryo development and tumourigenesis
- (2010) Yanlei Ma et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Plk4 is required for cytokinesis and maintenance of chromosomal stability
- (2010) C. O. Rosario et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 4: the odd one out of the family
- (2010) James E Sillibourne et al. Cell Division
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Centrosome abnormalities during aChlamydia trachomatisinfection are caused by dysregulation of the normal duplication pathway
- (2009) Kirsten A. Johnson et al. CELLULAR MICROBIOLOGY
- BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
- (2009) D. Rudolph et al. CLINICAL CANCER RESEARCH
- Control of Centriole Length by CPAP and CP110
- (2009) Thorsten I. Schmidt et al. CURRENT BIOLOGY
- MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
- (2009) Maria Angelica Cortez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma
- (2009) Rossella Pellegrino et al. HEPATOLOGY
- The SCFSlimbubiquitin ligase regulates Plk4/Sak levels to block centriole reduplication
- (2009) Gregory C. Rogers et al. JOURNAL OF CELL BIOLOGY
- Autophosphorylation of Polo-like Kinase 4 and Its Role in Centriole Duplication
- (2009) James E. Sillibourne et al. MOLECULAR BIOLOGY OF THE CELL
- A mechanism linking extra centrosomes to chromosomal instability
- (2009) Neil J. Ganem et al. NATURE
- Centrosome Amplification Can Initiate Tumorigenesis in Flies
- (2008) Renata Basto et al. CELL
- The SCF/Slimb Ubiquitin Ligase Limits Centrosome Amplification through Degradation of SAK/PLK4
- (2008) Inês Cunha-Ferreira et al. CURRENT BIOLOGY
- Genome instability: a mechanistic view of its causes and consequences
- (2008) Andrés Aguilera et al. NATURE REVIEWS GENETICS
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- (2008) C.-H. Yun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now